Itamar Medical Ltd. announced the appointment of Brad Fluegel to its Board of Directors. Mr. Fluegel’s vast experience includes wide ranging leadership roles and 25+ years in the healthcare sector, primarily in strategy and business development. Most recently, Mr. Fluegel was Senior Vice President, Chief Healthcare Commercial Market Development Officer for Walgreens Co. In this role he was responsible for driving all commercial healthcare activities, including sales and contracting, biopharma relationships, retail clinics, clinical affairs, new service development and market planning. Prior, he served as Walgreens’ Chief Strategy and Business Development officer. Prior to Walgreens, Mr. Fluegel was executive in residence at Health Evolution Partners. Earlier in his career, he was Executive Vice President, Chief Strategy and External Affairs Officer at Wellpoint (now Anthem) and as CEO for Reden & Anders and Tillinghast-Towers Perrin, a clinical, actuarial and management consulting practice serving all sectors of the health care industry. Mr. Fluegel currently serves on the Board of Directors of Metropolitan Jewish Health System in New York City, Performant Financial Corporation, Premera Blue Cross, Alight Solutions and AdhereHealth.